Drug development from phospholipids

被引：3

作者：

Unger, C

Eibl, H

机构：

[1] Univ Freiburg, Klin Tumorbiol, D-79106 Freiburg, Germany

[2] Max Planck Inst Biophys Chem, Gottingen, Germany

来源：

ONKOLOGIE | 2001年 / 24卷

关键词：

D O I：

10.1159/000055161

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：18 / 23

页数：6

共 18 条

[1]

BURDZY K, 1964, Z NATURFORSCH, V196, P1118

[2]

Burk Konrad, 1994, Drugs of Today, V30, P59

[3] HEXADECYLPHOSPHOCHOLINE - A NEW AND SELECTIVE ANTITUMOR DRUG [J].

EIBL, H ;

UNGER, C .

CANCER TREATMENT REVIEWS, 1990, 17 (2-3) :233-242

[4] A GENERAL SYNTHETIC METHOD FOR ENANTIOMERICALLY PURE ESTER AND ETHER LYSOPHOSPHOLIPIDS [J].

EIBL, H ;

WOOLLEY, P .

CHEMISTRY AND PHYSICS OF LIPIDS, 1988, 47 (01) :63-68

[5] SYNTHESIS OF ENANTIOMERICALLY PURE GLYCERYL ESTERS AND ETHERS .2. METHODS EMPLOYING THE PRECURSOR 3,4-ISOPROPYLIDENE-D-MANNITOL [J].

EIBL, H ;

WOOLLEY, P .

CHEMISTRY AND PHYSICS OF LIPIDS, 1988, 47 (01) :47-53

[6] SYNTHESIS OF ENANTIOMERICALLY PURE GLYCERYL ESTERS AND ETHERS .1. METHODS EMPLOYING THE PRECURSOR 1,2-ISOPROPYLIDENE-SN-GLYCEROL [J].

EIBL, H ;

WOOLLEY, P .

CHEMISTRY AND PHYSICS OF LIPIDS, 1986, 41 (01) :53-63

[7] CHARACTERIZATION OF THE ANTITUMOR-ACTIVITY OF HEXADECYLPHOSPHOCHOLINE (D-18506) [J].

HILGARD, P ;

STEKAR, J ;

VOEGELI, R ;

ENGEL, J ;

SCHUMACHER, W ;

EIBL, H ;

UNGER, C ;

BERGER, MR .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (09) :1457-1461

[8]

HILGARD P, 1994, CANCER CHEMOTH PHARM, V34, P293

[9] Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis [J].

Jha, TK ;

Sundar, S ;

Thakur, CP ;

Bachmann, P ;

Karbwang, J ;

Fischer, C ;

Voss, A ;

Berman, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (24) :1795-1800

[10] HEXADECYLPHOSPHOCHOLINE - ORAL TREATMENT OF VISCERAL LEISHMANIASIS IN MICE [J].

KUHLENCORD, A ;

MANIERA, T ;

EIBL, H ;

UNGER, C .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (08) :1630-1634

← 1 2 →